E.G7-OVA

Export PDF

Strain Information

Cell Line

E.G7-OVA

Cat. NO.

NM-S40-TM02

Model Description

E.G7-OVA cell line with OVA gene overexpression

Strain State

Validation of tumorigenic capacity completed

Validation Data

I. Characterization of in vivo growth kinetics

The E.G7-OVA cells were subcutaneously inoculated into the C57BL/6 mice.

image.png

Figure 1. Tumor growth curve of E.G7-OVA allogeneic model (n=5)

image.png

Figure 2. Body weight change of E.G7-OVA allogeneic model (n=5)

Related Strain(s)

CT26-OVA(2)
Cell Line：

CT26-OVA(2)

Cat. NO.：NM-S24A-TM34
E.G7-OVA-hCD24
Cell Line：

E.G7-OVA-hCD24

Cat. NO.：NM-S40-TM01
Panc02-OVA-Luc
Cell Line：Panc02-OVA-Luc
Cat. NO.：NMC-230050
KPC-OVA-Luc
Cell Line：

KPC-OVA-Luc

Cat. NO.：NMC-230049
CT26-OVA-Tg
Cell Line：

CT26-Tg(OVA)Smoc

Cat. NO.：NMC-230033

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more